Die diabetischen Folgeerkrankungen

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Der Internist

• Publication date

  2003-06-13

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00108-003-0996-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The natural history of stroke in diabetic patients.

  2009cited by this paper
• Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.

  2003cited by this paper
• Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography.

  2003cited by this paper
• Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects

  2002cited by this paper
• UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine

  2002cited by this paper
• Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank

  2001cited by this paper
• Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study.

  2001cited by this paper
• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.

  2000cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment?

  2000cited by this paper
• Hyperglycemia and cardiovascular disease in type 2 diabetes.

  1999cited by this paper
• Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy

  1999cited by this paper
• Erblindungsursachen in Hessen 1996

  1999cited by this paper
• Zur Pathogenese der diabetischen Podopathie

  1999cited by this paper
• Annual Report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy.

  1999cited by this paper
• The epidemiology of diabetic neuropathy

  1999cited by this paper
• Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

  1999cited by this paper
• Blindness Incidence in Germany

  1999cited by this paper
• [Pathogenesis of diabetic foot disease].

  1999cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

  1999cited by this paper
• Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.

  1999cited by this paper
• Effect of glycemia on mortality in Pima Indians with type 2 diabetes.

  1999cited by this paper
• Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial

  1998cited by this paper
• Multicenter Study of the Incidence of and Predictive Risk Factors for Diabetic Neuropathic Foot Ulceration

  1998cited by this paper
• Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.

  1998cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998cited by this paper
• Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

  1998cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.

  1997cited by this paper
• Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

  1997cited by this paper
• Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM

  1997cited by this paper
• Diabetic neuropathies

  1997cited by this paper
• Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study

  1997cited by this paper
• Lisinopril and albumin excretion in diabetes

  1997cited by this paper
• Diabetic nephropathy in type II diabetes.

  1996cited by this paper
• Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention

  1996cited by this paper
• Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up

  1996cited by this paper
• Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.

  1996cited by this paper
• Familial factors determine the development of diabetic nephropathy in patients with IDDM

  1996cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Advanced Glycation Endproducts Promote Adhesion Molecule (VCAM-1, ICAM-1) Expression and Atheroma Formation in Normal Rabbits

  1995cited by this paper
• The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects.

  1995cited by this paper
• The Independent Contributions of Diabetic Neuropathy and Yasculopatny in Foot Ulceration: How great are the risks?

  1995cited by this paper
• Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.

  1994cited by this paper
• Factors That Influence Outcome in Diabetic Subjects With Myocardial Infarction

  1993cited by this paper
• Lower-Extremity Amputations in Diabetic and Nondiabetic Patients: A population-based study in eastern Finland

  1993cited by this paper
• Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.

  1993cited by this paper
• Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group.

  1993cited by this paper
• Risk factors for death from different types of stroke

  1993cited by this paper
• Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers

  1993cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• The link between hyperglycaemia and diabetic nephropathy

  1992cited by this paper
• Autonomic neuropathy and prolongation of QT-interval in liver disease.

  1992cited by this paper
• The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

  1989cited by this paper
• Diabetic nephropathy: structural-functional relationships.

  1989cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.

  1987cited by this paper
• DIABETIC MACULAR EDEMA: A REVIEW

  1986cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

  1984cited by this paper
• Predicting diabetic nephropathy in insulin-dependent patients.

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

  1984cited by this paper
• Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

  1983cited by this paper
• Diabetes and Cardiovascular Risk Factors: The Framingham Study

  1979cited by this paper
• Tegretol in the treatment of diabetic neuropathy.

  1974cited by this paper

• Theaflavin-3,3'-Digallate Protects Liver and Kidney Functions in Diabetic Rats by Up-Regulating Circ-ITCH and Nrf2 Signaling Pathway.

  2024cites this paper
• Impact of Reduction in Pill Load Upon Use of a Once Weekly DPP-4 Inhibitor in 2 Cases of Type 2 Diabetes

  2022cites this paper
• Comparison of the effects of remifentanil-based general anesthesia and popliteal nerve block on postoperative pain and hemodynamic stability in diabetic patients undergoing distal foot amputation

  2016cites this paper
• Diagnosis & dietary intervention in patients with diabetic gastroparesis

  2013cites this paper
• Relationship Between Glycosylated Hemoglobin Level and Sciatic Nerve Block Performance in Diabetic Patients

  2013cites this paper
• Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy.

  2010cites this paper
• Hypertonie beim Diabetes mellitus

  2005cites this paper
• Neuropsychologische Leistungsprofile bei Patienten mit Diabetes mellitus in Abhängigkeit von ihrer Stoffwechseleinstellung

  2005cites this paper
• The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals.

  2004cites this paper